STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
DCPH DECIPHERA PHARMACEUTICALS INCORPORATED StockScouter® Report
7
StockScouter® Score
DECIPHERA PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
- One or more less experienced analysts has modestly increased quarterly earnings estimates for DCPH. Positive/Neutral
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Two or more executives, directors or major shareholders sold a small number of shares recently. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
A
D
D
B